SYSTEMIC INFLAMMATORY DISEASES (SIDS), WHAT—S IN A NAME

REFERENCES

• Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223–43.
   PubMedGoogle Scholar
• de Kleijn EMHA, Vandenbroucke JP, van der Meer JWM, and the Netherlands FUO study group. Fever of unknown origin (FUO) I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine 1997; 76: 392–400.
   Web of Science ®Google Scholar
• Luqmani RA, Pathare S, Kwok-Fai TL. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 321–36.
   Web of Science ®Google Scholar
• Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005; 80: 671–3.
   PubMed Web of Science ®Google Scholar
• Van Camp G, Flamez A, Cosyns B, et al. Treatment of Parkinson’s disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004; 363: 1179–83.
   PubMed Web of Science ®Google Scholar
• Waller EA, Kaplan J, Heckman MG. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2005; 80: 1016–20.
   PubMed Web of Science ®Google Scholar
• Pritchett AM, Morrison JF, Edwards WD, et al. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77: 1280–6.
   PubMed Web of Science ®Google Scholar
• Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352: 362–72.
   PubMed Web of Science ®Google Scholar
• DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656–68.
   PubMed Web of Science ®Google Scholar
• Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338–46.
   PubMed Web of Science ®Google Scholar
• Schiffmann R, Ries M. Fabry’s disease – an important risk factor for stroke. Lancet 2005; 366: 1754–6.
   Web of Science ®Google Scholar
• Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Cuur Opin Rheumatol 2005; 17: 586–99.
   PubMed Web of Science ®Google Scholar
• Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease. Medicine 2004; 83: 371–92.
   PubMed Web of Science ®Google Scholar
• Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005; 19: 191–207.
   PubMed Web of Science ®Google Scholar
• Saleh A, Stone JH. Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 209–21.
   Web of Science ®Google Scholar
• Lane SE, Watts RA, Shepstone L, Scott DGI. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98: 97–111.
   Google Scholar
• Somer T, Finegold SM. Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995; 20: 1010–36.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–92.
   PubMed Web of Science ®Google Scholar
• Oliveira GH, Seward JB, Tsang TS, Specks U. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc 2005; 80: 1435–40.
   PubMed Web of Science ®Google Scholar
• Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683–90.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine 1999; 78: 292–308.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134: 382–6.
   Web of Science ®Google Scholar
• Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122: 502–7.
   PubMed Web of Science ®Google Scholar
• Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114–22.
   PubMed Web of Science ®Google Scholar